Role of chelates in treatment of cancer

46Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Chelates are used in cancer as cytotoxic agent, as radioactive agent in imaging studies and in radioimmunotherapy. Various chelates based on ruthenium, copper, zinc, organocobalt, gold, platinum, palladium, cobalt, nickel and iron are reported as cytotoxic agent. Monoclonal antibodies labeled with radioactive metals such as yttrium-90, indium-111 and iodine-131 are used in radioimmunotherapy. This review is an attempt to compile the use of chelates as cytotoxic drugs and in radioimmunotherapy.

Cite

CITATION STYLE

APA

Tripathi, L., Kumar, P., & Singhai, A. K. (2007). Role of chelates in treatment of cancer. Indian Journal of Cancer, 44(2), 62–71. https://doi.org/10.4103/0019-509X.35813

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free